Related Experiment Video

Updated: Jan 8, 2026

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

28.0K

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis

Sara Charmsaz1, Ben Doherty1, Sinéad Cocchiglia1

  • 1Endocrine Oncology Research Group, Department of Surgery, Royal College of Surgeons in Ireland, Dublin 2, Ireland.

BMC Medicine
|December 13, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
08:36

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI

Published on: March 6, 2014

19.5K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.7K

Related Experiment Videos

Last Updated: Jan 8, 2026

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
07:43

Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis

Published on: February 8, 2017

28.0K
Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
08:36

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI

Published on: March 6, 2014

19.5K
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

3.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

Articles linked to this work by shared authors, journal, and citation graph.

Breast cancer ovarian metastases show increased activity of GPCR pathways.

bioRxiv : the preprint server for biology·2026

Novel transplantable mouse cell line model recapitulates invasive lobular breast carcinoma (ILC) phenotype and immune microenvironment.

bioRxiv : the preprint server for biology·2026

Polydopamine Nanotubes: Multifunctional Smart Nanotransducers for Cellular Activity Modulation.

ACS nano·2026

A dependency map enhanced with next-generation 3D cancer models.

Nature·2026

Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women.

Nature aging·2026

What should medical students learn in immunology? Developing a consensus-based curriculum framework for a spiral medical curriculum.

Irish journal of medical science·2026

Systemic immune activation in hereditary cancer predisposition syndromes: a cross-sectional study.

BMC medicine·2026

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

BMC medicine·2026

JP1 peptide modulates oxidative stress and autophagy via Keap1-Nrf2-ARE in ALS model mice.

BMC medicine·2026

Sex-specific signatures of fetal programming for gestational diabetes mellitus in umbilical cord: A cohort study from Tanzania.

BMC medicine·2026

Microvascular remodeling and endothelial dysfunction across the post-COVID-19 spectrum: a prospective observational case-control study.

BMC medicine·2026

Artificial intelligence-enhanced management system for secondary prevention of coronary heart disease: a randomized clinical trial.

BMC medicine·2026

A marine-derived meroterpenoid inhibits colorectal cancer via PI3K pathway modulation in mice.

Marine life science & technology·2026

Noncoding RNA encoded peptides in tumors from discovery to mechanism and clinical translation.

iScience·2026

SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.

Journal of molecular and cellular cardiology plus·2026

Efficacy and safety of SCT200 in patients with recurrent or metastatic head and neck squamous cell carcinoma after platinum failure: A phase 2 study.

Cancer pathogenesis and therapy·2026

Rapamycin Attenuates Acute Pancreatitis-Induced Acinar Injury in Mice With Pancreatic Loss of Gα13.

Gastro hep advances·2026

PTC124 promotes mutation site-dependent readthrough of STK11 nonsense mutations and restores tumor suppressor function.

BBA advances·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us